Naoya Sakamoto

14PUBLICATIONS
54CO-AUTHORS
Metabolic medicinePredictive and prognostic markersPeriodonticsGastroenterology and hepatologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2026
Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.

|Sep 11, 2026
Serum Leucine-Rich α2-Glycoprotein 1 Identifies Cachexia in Patients With Liver Cirrhosis and/or Hepatocellular Carcinoma Having Low C-Reactive Protein Levels.

|Jun 26, 2026
Comprehensive Evaluation of Oral Diseases in Patients with Gastrointestinal Cancers: Epidemiological Evidence from a 10-Year Retrospective Study.

|Dec 13, 2025
Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water Retention.

Masato Nakai, Masatsugu Ohara, Daisuke Yokoyama

|Nov 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Federica Lo Prinzi, Federico Rossari, Antonio De Rosa

|Sep 29, 2025
Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug-Induced Liver Injury.

Kosuke Saito, Tatehiro Kagawa, Keiji Tsuji

Pageof 3

Frequent Collaborators

6 joint publications

Goki Suda

4 joint publications

Masato Nakai

3 joint publications

Masatsugu Ohara

3 joint publications

Takuya Sho